Next Article in Journal
Efficacy of Indirect Decompression by Posterior Longitudinal Ligament Ligamentotaxis in Minimally Invasive Oblique Lateral Interbody Fusion (MIS-OLIF) Without Posterior Decompression for Degenerative Lumbar Disease
Previous Article in Journal
Added Value of One-Month Clinical Data in Predicting Chronic-Stage Motor Function After Ischemic Stroke
Previous Article in Special Issue
Associations of Anxiety and Depression and Hypomanic Traits with Self-Informant Discrepancies in Adults First Diagnosed with ADHD in Adulthood: A Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

ADHD: Beyond Core Symptoms and Specialist Care

by
Rafał R. Jaeschke
Section of Biological and Community Psychiatry, Department of Psychiatry, Jagiellonian University Medical College, 31-501 Kraków, Poland
J. Clin. Med. 2026, 15(17), 6570; https://doi.org/10.3390/jcm15176570
Submission received: 3 August 2026 / Accepted: 17 August 2026 / Published: 26 August 2026
Attention-deficit/hyperactivity disorder (ADHD) is still too often regarded as a marginal or highly specialist concern, rather than as a condition with direct relevance to everyday clinical practice [1]. This misconception has consequences at both the individual and public health levels. It adds to the lifelong suffering of many patients with ADHD and contributes to substantial health-related and occupational burden [2,3]. Unless this often-overlooked contributor to disability and ill health is recognized and addressed, efforts to optimize treatment may fall short of what patients need.
The clinical burden of ADHD extends well beyond its defining symptoms. Psychiatric comorbidity is common across the lifespan [4,5], while adult ADHD is also associated with physical multimorbidity [6], sleep problems [7], and increased mortality risk [8]. Treatment research further suggests that improvement in core symptoms does not necessarily translate into equivalent gains in broader outcomes, including quality of life [9]. These problems are not peripheral to ADHD simply because they fall outside its diagnostic criteria: they may shape diagnostic interpretation, treatment choice, monitoring, prognosis, and day-to-day functioning.
The contributions to this Special Issue approach this broader clinical field from different angles, spanning assessment and informant discrepancies, addiction-related treatment context, menstrual-cycle-related variation, patterns of medication use, sleep and circadian factors, and educationally relevant cognitive function [10,11,12,13,14,15]. Read together, they do not propose another catalogue of problems to be appended to ADHD. Rather, they show that the clinical meaning of the disorder depends partly on the conditions, contexts, and functional demands surrounding its defining symptoms. Some of these observations already bear directly on assessment or treatment; others remain primarily explanatory and may acquire greater clinical relevance as the evidence develops.
The task, then, is neither to make ADHD an explanation for every difficulty nor to reduce it to the symptoms required for diagnosis. Clinical precision requires both: a clear definition of the disorder and attention to the wider problems that shape a patient’s health, functioning, and treatment. In that sense, bridging theory and clinical application means moving beyond the diagnostic core without losing sight of it. We hope this Special Issue invites readers to do precisely that.

Funding

This research received no external funding.

Acknowledgments

While preparing this manuscript, the author utilized OpenAI GPT-5.6 Sol to help synthesize the literature, draft and revise the manuscript, and improve language and clarity. The author reviewed and edited all AI-generated content, maintaining full scholarly and editorial responsibility for the final publication.

Conflicts of Interest

The author served as Guest Editor for the Special Issue “Attention-Deficit–Hyperactivity Disorder (ADHD): Bridging Theory and Clinical Application” and declares no other conflicts of interest.

References

  1. Schneider, B.C.; Schöttle, D.; Hottenrott, B.; Gallinat, J.; Moritz, S. Assessment of Adult ADHD in Clinical Practice: Four Letters–40 Opinions. J. Atten. Disord. 2023, 27, 1051–1061. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  2. Taipale, H.; Bergström, J.; Gèmes, K.; Tanskanen, A.; Ekselius, L.; Mittendorfer-Rutz, E.; Helgesson, M. Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes. JAMA Netw. Open 2024, 7, e242859. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  3. Helgesson, M.; Björkenstam, E.; Rahman, S.; Gustafsson, K.; Taipale, H.; Tanskanen, A.; Ekselius, L.; Mittendorfer-Rutz, E. Labour Market Marginalisation in Young Adults Diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD): A Population-Based Longitudinal Cohort Study in Sweden. Psychol. Med. 2023, 53, 1224–1232. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  4. Faraone, S.V.; Banaschewski, T.; Coghill, D.; Zheng, Y.; Biederman, J.; Bellgrove, M.A.; Newcorn, J.H.; Gignac, M.; Al Saud, N.M.; Manor, I.; et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-Based Conclusions about the Disorder. Neurosci. Biobehav. Rev. 2021, 128, 789–818. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  5. Choi, W.-S.; Woo, Y.S.; Wang, S.-M.; Lim, H.K.; Bahk, W.-M. The Prevalence of Psychiatric Comorbidities in Adult ADHD Compared with Non-ADHD Populations: A Systematic Literature Review. PLoS ONE 2022, 17, e0277175. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  6. Stickley, A.; Koyanagi, A.; Takahashi, H.; Ruchkin, V.; Inoue, Y.; Kamio, Y. Attention-Deficit/Hyperactivity Disorder and Physical Multimorbidity: A Population-Based Study. Eur. Psychiatry 2017, 45, 227–234. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  7. Díaz-Román, A.; Mitchell, R.; Cortese, S. Sleep in Adults with ADHD: Systematic Review and Meta-Analysis of Subjective and Objective Studies. Neurosci. Biobehav. Rev. 2018, 89, 61–71. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  8. Catalá-López, F.; Hutton, B.; Page, M.J.; Driver, J.A.; Ridao, M.; Alonso-Arroyo, A.; Valencia, A.; Macías Saint-Gerons, D.; Tabarés-Seisdedos, R. Mortality in Persons with Autism Spectrum Disorder or Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Pediatr. 2022, 176, e216401. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  9. Ostinelli, E.G.; Schulze, M.; Zangani, C.; Farhat, L.C.; Tomlinson, A.; Del Giovane, C.; Chamberlain, S.R.; Philipsen, A.; Young, S.; Cowen, P.J.; et al. Comparative Efficacy and Acceptability of Pharmacological, Psychological, and Neurostimulatory Interventions for ADHD in Adults: A Systematic Review and Component Network Meta-Analysis. Lancet Psychiatry 2025, 12, 32–43. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  10. Song, J.; Li, Y.; Xu, J. Associations of Anxiety and Depression and Hypomanic Traits with Self-Informant Discrepancies in Adults First Diagnosed with ADHD in Adulthood: A Cross-Sectional Study. J. Clin. Med. 2026, 15, 3965. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  11. Żełabowski, K.; Petrov, W.; Ślebioda, D.; Rusinek, M.; Biedka, K.; Błaszczyk, K.; Wesołowski, M.; Wojtysiak, K.; Sroka, M.; Ratka, Z.; et al. Holistic Management of Adult ADHD with a History of Addiction: Emphasis on Low-Addiction-Risk Psychopharmacotherapy. J. Clin. Med. 2025, 14, 6470. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  12. Wynchank, D.; Sutrisno, R.M.G.T.M.F.; van Andel, E.; Kooij, J.J.S. Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning—A Narrative Review. J. Clin. Med. 2026, 15, 121. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  13. Rzeszutek, M.; Wolańczyk, T. Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns—A Narrative Review. J. Clin. Med. 2025, 14, 7338. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  14. Jaeschke, R.R.; Sułkowska, J.Z. Methylphenidate, Sleep, and the “Stimulant Paradox” in Adult ADHD: A Conceptual Framework for Integrating Chronopharmacotherapy and Coaching. J. Clin. Med. 2025, 14, 8494. [Google Scholar] [CrossRef] [Scilit] [PubMed]
  15. Piccolo, A.; La Fauci, M.; De Domenico, C.; Di Cara, M.; Fulgenzi, A.; Mancuso, N.; Bonanno, L.; Tresoldi, M.; Muratore, R.; Impallomeni, C.; et al. The Impact of Executive Functions on Metaphonological Skills: Correlation and Treatment Implication for ADHD Children. J. Clin. Med. 2026, 15, 906. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jaeschke, R.R. ADHD: Beyond Core Symptoms and Specialist Care. J. Clin. Med. 2026, 15, 6570. https://doi.org/10.3390/jcm15176570

AMA Style

Jaeschke RR. ADHD: Beyond Core Symptoms and Specialist Care. Journal of Clinical Medicine. 2026; 15(17):6570. https://doi.org/10.3390/jcm15176570

Chicago/Turabian Style

Jaeschke, Rafał R. 2026. "ADHD: Beyond Core Symptoms and Specialist Care" Journal of Clinical Medicine 15, no. 17: 6570. https://doi.org/10.3390/jcm15176570

APA Style

Jaeschke, R. R. (2026). ADHD: Beyond Core Symptoms and Specialist Care. Journal of Clinical Medicine, 15(17), 6570. https://doi.org/10.3390/jcm15176570

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop